Avidity (RNA) Moves Date for Shareholder Vote on Novartis Merger

Avidity Biosciences Inc. (NASDAQ:RNA) is one of 15 stocks with the biggest hedge fund momentum, after gaining 28 hedge fund holders during the fourth quarter of 2025. On February 23, Avidity Biosciences Inc. (NASDAQ:RNA) adjourned its special stockholder meeting scheduled for the same day and moved the date to February 26. Avidity Biosciences Inc. (NASDAQ:RNA) said it needs additional time to satisfy conditions for the distribution of all outstanding shares of Atrium Therapeutics Inc. to Avidity stockhol ...